TDP-43 loss of function drives aberrant splicing in Parkinson's disease
Demonstrated that TDP-43 loss of function drives aberrant splicing events in Parkinson's disease.
james-w.-brenton
•
•
1 min read
Broad brain biodistribution conferred by an AAV to restore TDP-43 function mitigates Frontotemporal Dementia-like deficits
Demonstrated that AAV-delivered chimeric TDP-43 repressor (CTR) achieves broad brain biodistribution, restores TDP-43 splicing function, rescues neurons, and mitigates FTD-like …
Depletion of TDP-43 exacerbates tauopathy-dependent brain atrophy by sensitizing vulnerable neurons to caspase 3-mediated endoproteolysis of tau in a mouse model of Multiple Etiology Dementia
TDP-43 depletion exacerbates tauopathy-dependent brain atrophy by sensitizing neurons to caspase 3-mediated tau cleavage in a multiple etiology dementia mouse model.
manoj-s.-baghel
Validation of TDP-43 Splicing Repression as a Therapeutic Strategy for ALS and FTD
Conference abstract presented at ASGCT 2024 on validating TDP-43 splicing repression as a therapeutic strategy for ALS and FTD.